LRRK2 and Parkinson disease: The majority of the reported LRRK2 pathogenic variant-positive PD patients are of European descent (63%), whereas all other ethnicities comprise ~10% or fewer patients of described pathogenic variant carriers despite clusters in the Ashkenazi Jewish (AJ) and Arab Berber populations (1, 2).